Ireland
--:--IST
Latest
Clinical Trials in Mexico / NCT04432883
Recruiting Not applicable

Targeted TDCS to Enhance Speech-Language Treatment Outcome in Persons With Chronic Post-Stroke Aphasia.

NCT04432883 · tracked via the Priya Life Science Mexico tracker
Phase
Not applicable
Started
2022-10-18
Last updated
2026-05-22

Condition(s) studied

StrokeAphasia

Investigational drug(s) / intervention(s)

Active Comparator: Experimental: Active cathodal tDCS + language trainingSham Comparator: Placebo cathodal tDCS + Speech and language

Active Comparator: Experimental: Active cathodal tDCS + language training: Cathodal tDCS raises neuronal membrane potentials, leading to decreased probability of depolarization from incoming stimuli. Speech and Language training involves a combined semantic feature analysis and phonological components analysis treatment.

Sham Comparator: Placebo cathodal tDCS + Speech and language: Speech and Language training involves a combined semantic feature analysis and phonological components analysis treatment. .

Study summary

62 patients who are one year post stroke and have Aphasia as a result of that stroke will be recruited. Participants will have 4 assessment sessions and 15 treatment sessions. The TDCS will be to right Inferior Frontal Gyrus (IFG) (25 active, 25 sham) for 15 days. A combined semantic feature analysis/phonological components analysis treatment will be paired with the stimulation. Two assessment sessions will be pretreatment, 1 session immediately post-treatment, and 1 session at 3 months follow-up.

Eligibility

Sex
ALL
Min age
25 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria: 1. aged 25-85 2. must be greater than 6 months post-stroke 3. must have a diagnosis of aphasia based on impaired performance on the Western Aphasia Battery-Revised, Boston Naming Test, or during discourse production 4. must be left-hemisphere dominant as demonstrated by aphasia onset subsequent to left hemisphere damage 5. must be stimulable for naming Exclusion Criteria: 1. comorbid neurological disease. 2. damage to the anterior right hemisphere. 3. significant mood disorder. 4. substance/alcohol dependence or abuse within the past year 5. presence of any implanted electrical device or contraindications to tDCS or MRI 6. recent medical instability (within 4 weeks) 7. pregnancy

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of New Mexico Center for Brain Recovery and Repair Albuquerque New Mexico Recruiting

More University of New Mexico trials in Mexico

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04432883 on ClinicalTrials.gov ↗ ← All trials in Mexico